Literature DB >> 33927348

The HTLV-1 proviral status is a potential prognostic biomarker for adult T-cell leukemia-lymphoma treated with allogeneic stem cell transplantation.

Kosuke Toyoda1,2, Jun-Ichirou Yasunaga3,4, Ilseung Choi5, Youko Suehiro5,6, Naokuni Uike7, Jun Okamura8, Masao Matsuoka1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33927348     DOI： 10.1038/s41409-021-01311-z

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.174


× No keyword cloud information.
  9 in total

1.  Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study.

Authors:  Takashi Ishida; Masakatsu Hishizawa; Koji Kato; Ryuji Tanosaki; Takahiro Fukuda; Shuichi Taniguchi; Tetsuya Eto; Yoshifusa Takatsuka; Yasushi Miyazaki; Yukiyoshi Moriuchi; Michihiro Hidaka; Koichi Akashi; Naokuni Uike; Hisashi Sakamaki; Yasuo Morishima; Koji Kato; Ritsuro Suzuki; Takeshi Nishiyama; Atae Utsunomiya
Journal:  Blood       Date:  2012-06-11       Impact factor: 22.113

2.  GVL for ATL?

Authors:  Nirali N Shah; Thomas A Waldmann
Journal:  Blood       Date:  2013-01-03       Impact factor: 22.113

3.  APOBEC3G generates nonsense mutations in human T-cell leukemia virus type 1 proviral genomes in vivo.

Authors:  Jun Fan; Guangyong Ma; Kisato Nosaka; Junko Tanabe; Yorifumi Satou; Atsushi Koito; Simon Wain-Hobson; Jean-Pierre Vartanian; Masao Matsuoka
Journal:  J Virol       Date:  2010-05-12       Impact factor: 5.103

4.  Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study.

Authors:  Junya Kanda; Masakatsu Hishizawa; Atae Utsunomiya; Shuichi Taniguchi; Tetsuya Eto; Yukiyoshi Moriuchi; Ryuji Tanosaki; Fumio Kawano; Yasushi Miyazaki; Masato Masuda; Koji Nagafuji; Masamichi Hara; Minoko Takanashi; Shunro Kai; Yoshiko Atsuta; Ritsuro Suzuki; Takakazu Kawase; Keitaro Matsuo; Tokiko Nagamura-Inoue; Shunichi Kato; Hisashi Sakamaki; Yasuo Morishima; Jun Okamura; Tatsuo Ichinohe; Takashi Uchiyama
Journal:  Blood       Date:  2012-01-10       Impact factor: 22.113

5.  Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.

Authors:  S Jacobson; H Shida; D E McFarlin; A S Fauci; S Koenig
Journal:  Nature       Date:  1990-11-15       Impact factor: 49.962

6.  Human T-cell lymphotropic virus HBZ and tax mRNA expression are associated with specific clinicopathological features in adult T-cell leukemia/lymphoma.

Authors:  Kyohei Yamada; Hiroaki Miyoshi; Noriaki Yoshida; Joji Shimono; Kensaku Sato; Kazutaka Nakashima; Mai Takeuchi; Fumiko Arakawa; Naoko Asano; Eriko Yanagida; Masao Seto; Koichi Ohshima
Journal:  Mod Pathol       Date:  2020-09-24       Impact factor: 7.842

7.  Preferential selection of human T-cell leukemia virus type 1 provirus lacking the 5' long terminal repeat during oncogenesis.

Authors:  Maki Miyazaki; Jun-Ichirou Yasunaga; Yuko Taniguchi; Sadahiro Tamiya; Tatsutoshi Nakahata; Masao Matsuoka
Journal:  J Virol       Date:  2007-03-07       Impact factor: 5.103

8.  Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report.

Authors:  Lucy B Cook; Shigeo Fuji; Olivier Hermine; Ali Bazarbachi; Juan Carlos Ramos; Lee Ratner; Steve Horwitz; Paul Fields; Alina Tanase; Horia Bumbea; Kate Cwynarski; Graham Taylor; Thomas A Waldmann; Achilea Bittencourt; Ambroise Marcais; Felipe Suarez; David Sibon; Adrienne Phillips; Matthew Lunning; Reza Farid; Yoshitaka Imaizumi; Ilseung Choi; Takashi Ishida; Kenji Ishitsuka; Takuya Fukushima; Kaoru Uchimaru; Akifumi Takaori-Kondo; Yoshiki Tokura; Atae Utsunomiya; Masao Matsuoka; Kunihiro Tsukasaki; Toshiki Watanabe
Journal:  J Clin Oncol       Date:  2019-01-18       Impact factor: 44.544

9.  The roles of acquired and innate immunity in human T-cell leukemia virus type 1-mediated diseases.

Authors:  Mari Kannagi; Atsuhiko Hasegawa; Ayako Takamori; Shuichi Kinpara; Atae Utsunomiya
Journal:  Front Microbiol       Date:  2012-09-03       Impact factor: 5.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.